Differences in Cardiometabolic Proteins in Pregnancy Prioritize Relevant Targets of Preeclampsia
Arteriosclerosis, Thrombosis, and Vascular Biology, 2024
Lindley K., Perry A., Jacobs M., Petty L., Amancherla K., Zhao S., Barker C., Davila-Roman V., Khan S., Osmundson S., Tanriverdi K., Freedman J., Below J., Shah R., Laurent L.
| Disease area | Application area | Sample type | Products |
|---|---|---|---|
Obstetrics | Pathophysiology Patient Stratification | Plasma |  Olink Explore 3072/384 |
Abstract
BACKGROUND:
Preeclampsia is a hypertensive disorder of pregnancy characterized by widespread vascular inflammation. It occurs frequently in pregnancy, often without known risk factors, and has high rates of maternal and fetal morbidity and mortality. Identification of biomarkers that predict preeclampsia and its cardiovascular sequelae before clinical onset, or even before pregnancy, is a critical unmet need for the prevention of adverse pregnancy outcomes.
METHODS:
We explored differences in cardiovascular proteomics (Olink Explore 384) in 256 diverse pregnant persons across 2 centers (26% Hispanic, 21% Black).
RESULTS:
We identified significant differences in plasma abundance of markers associated with angiogenesis, blood pressure, cell adhesion, inflammation, and metabolism between individuals delivering with preeclampsia and controls, some of which have not been widely described previously and are not represented in the preeclampsia placental transcriptome. While we observed a broadly similar pattern in early (<34 weeks) versus late (≥34 weeks) preeclampsia, several proteins related to hemodynamic stress, hemostasis, and immune response appeared to be more highly dysregulated in early preeclampsia relative to late preeclampsia.
CONCLUSIONS:
These results demonstrate the value of performing targeted proteomics using a panel of cardiovascular biomarkers to identify biomarkers relevant to preeclampsia pathophysiology and highlight the need for larger multiomic studies to define modifiable pathways of surveillance and intervention upstream to preeclampsia diagnosis.